![]() acetylsalicylsalicylic acid structure
|
Common Name | acetylsalicylsalicylic acid | ||
---|---|---|---|---|
CAS Number | 530-75-6 | Molecular Weight | 300.263 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 540.1±35.0 °C at 760 mmHg | |
Molecular Formula | C16H12O6 | Melting Point | 153-160ºC | |
MSDS | N/A | Flash Point | 203.9±19.4 °C |
[A new possible strategy for prevention and preventive treatment of age-related macular degeneration resting on recent clinical and pathophysiological observations].
Orv. Hetil. 150(11) , 503-12, (2009) The beneficial effect achieved by the treatment of endothelial dysfunction in chronic cardiovascular diseases is already an evidence belonging to the basic treatment of the disease. Given the fact that the vascular system is uniform and consubstantial both ph... |
|
Solid-state stability of aspirin in the presence of excipients: kinetic interpretation, modeling, and prediction.
J. Pharm. Sci. 71(10) , 1096-101, (1982) Salicylsalicylic acid and acetylsalicylsalicylic acid were identified as decomposition products of aspirin when mixtures of the drug, with magnesium stearate, were stored in the solid state of 60 degrees and 75% relative humidity. The effect of increasing the... |
|
Aspirin--a national survey III: Determination of impurities in bulk aspirin and aspirin formulations by high-pressure liquid chromatography and spectrophotometry.
J. Pharm. Sci. 69(5) , 550-3, (1980) A quantitative high-pressure liquid chromatographic method, using a reversed-phase column and an aqueous acetic acid-methanol solution as the mobile phase, was employed for the determination of O-acetyl-O-salicylsalicylic acid and O-salicylsalicylic acid in p... |
|
The quantitative determination of aspirin and its degradation products in a model solution aerosol.
J. Pharm. Biomed. Anal. 13(2) , 111-9, (1995) Formulation of pressurized aerosol solutions in propellants for inhalation requires the use of high quantities of surfactants to solubilize the drug. Due to the lipophilic nature of these surfactants, analytical difficulties are created for those wishing to q... |
|
Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms.
Eur. Neurol. 52(1) , 50-6, (2004) Recently a new effervescent acetylsalicylic acid (ASA) tablet with high buffering capacity has been developed. In this double-blind, 3-arm, multicenter, parallel-group study, 433 patients were treated either with 1,000 mg effervescent ASA or 50 mg encapsulate... |
|
Measurement of primary haemostasis using a pressure clamp technique.
Platelets 12(8) , 462-70, (2001) With the PFA-100 a sensitive and specific screening test for primary haemostasis has recently become available. An important part of the device is a capillary, providing a defined haemodynamic resistance for the perfusion of the aperture. A modified method to... |
|
Hydrolysis of acetylsalicylsalicylic acid and salicylsalicylic acid in aqueous solution.
Chem. Pharm. Bull. 33(5) , 2158-61, (1985)
|